Innate Pharma S.A. ADS
N/A
USD
N/A
N/A
...
Chart
Financials
Description
IPHA Company Description
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.
IPHA Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view IPHA Smart Score
Score Breakdown
IPHA Company Description
Show More
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of IPHA by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by IPHA's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
Twitter
Followers on IPHA's company Twitter account
WallStreetBets
Number of mentions of IPHA in WallStreetBets Daily Discussion
IPHA News
Recent insights relating to IPHA
CNBC Recommendations
Recent picks made for IPHA stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in IPHA
Corporate Flights
Flights by private jets registered to IPHA
Our Analysis